300705 Hunan Jiudian Pharmaceutical
- 18.06
- -0.34-1.85%
Hunan Jiudian Pharmaceutical News
Jiudian Pharmaceutical: Progress Announcement on Providing Guarantees for Wholly-owned Subsidiaries
Hunan Jiudian Pharmaceutical: Internal Control System (Revised August 2024)
Hunan Jiudian Pharmaceutical: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Hunan Jiudian Pharmaceutical: Announcement regarding the adjustment of the investment project plan progress of part of the raised funds.
Hunan Jiudian Pharmaceutical: Announcement regarding investment and related party transactions with professional investment institutions.
Hunan Jiudian Pharmaceutical: Announcement on Withdrawal of Pharmaceutical Registration Application.
Hunan Jiudian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to stocks in Q2 2024.
Hunan Jiudian Pharmaceutical: Hunan Jiudian Pharmaceutical Co., Ltd. issued a temporary trust management report for the convertible corporate bonds issued to unspecified investors.
Hunan Jiudian Pharmaceutical: Hunan Jiudian Pharmaceutical Co., Ltd., listed on the Growth Enterprise Market, issued periodic convertible corporate bond rating reports to unspecified investors.
Hunan Jiudian Pharmaceutical: Report on entrusted management of convertible enterprise bonds issued by the company to unspecified objects (2023 Annual)
Hunan Jiudian Pharmaceutical: Announcement on the progress of matters relating to the adjustment of joint investment with professional investment institutions and related transactions
Hunan Jiudian Pharmaceutical: Announcement on the abolition of some restricted stocks
Hunan Jiudian Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hunan Jiudian Pharmaceutical: Hunan Qiyuan Law Firm's Legal Opinion on the Company's 2023 Annual General Meeting of Shareholders
Hunan Jiudian Pharmaceutical: Announcement on the change in the ratio of bondholders' convertible bonds to 10%
Hunan Jiudian Pharmaceutical: Announcement on cancellation of pledges for convertible corporate bonds held by shareholders holding 5% or more of the shares
Jiudian Pharmaceutical: 2024 Financial Budget Report
Jiudian Pharmaceutical: 2023 Financial Results Report
Jiudian Pharmaceutical: Announcement on providing guarantees for wholly-owned subsidiaries to apply for bank credit
Jiudian Pharmaceutical: Announcement on Adjusting Matters and Related Transactions Related to Joint Investment with Professional Investment Institutions
Analysis
Price Target
No Data
No Data